BRCA1 and ovarian cancer: Based on a cohort of 316 ovarian cancer patients taken from TCGA, 77.8 % had BRCA1/2 wild type, 8.5 % had germline mutations, 3.1 % had somatic mutations, and 10.4 % had BRCA1 hypermethylation.